热门资讯> 正文
iTeos Therapeutics任命David Feltquate为首席医疗官
2024-08-05 19:20
- iTeos Therapeutics (NASDAQ:ITOS) said it has appointed David Feltquate as its chief medical officer.
- Feltquate has nearly 20 years of immuno-oncology clinical development, translational medicine, and diagnostic assay advancement experience.
More on iTeos Therapeutics
- iTeos Therapeutics: Rippling Waves Of TIGIT Pessimism
风险及免责提示:以上内容仅代表作者的个人立场和观点,不代表华盛的任何立场,华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前,应结合自身情况,考虑投资产品的风险。必要时,请咨询专业投资顾问的意见。华盛不提供任何投资建议,对此亦不做任何承诺和保证。